(Q42508741)

1 November 2017

title

Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: a pilot prospective study (English)

1 reference

polycystic ovary syndrome

1 November 2017

0 references

1 reference

1 reference

Fulghesu AM

1

1 reference

1 November 2017

Ciampelli M

2

1 reference

1 November 2017

Belosi C

3

1 reference

1 November 2017

Apa R

4

1 reference

1 November 2017

Guido M

5

1 reference

1 November 2017

Caruso A

6

1 reference

1 November 2017

Mancuso S

7

1 reference

1 November 2017

Lanzone A

8

1 reference

1 November 2017

publication date

1 July 2001

1 reference

Journal of Endocrinological Investigation

1 November 2017

published in

1 reference

1 November 2017

volume

24

1 reference

1 November 2017

issue

7

1 reference

1 November 2017

page(s)

483-490

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03343880

1 November 2017

exact match

0 references

cites work

Insulin and polycystic ovary syndrome: a new look at an old subject.

1 reference

https://api.crossref.org/works/10.1007%2FBF03343880

Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343880

Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343880

Current and future status of ovulation induction in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343880

Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343880

Central opioid activity in polycystic ovary syndrome with and without dopaminergic modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343880

Evidence for decreased endogenous dopamine and opioid inhibitory influences on LH secretion in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343880

Genotyping Steroid 21-Hydroxylase Deficiency: Hormonal Reference Data*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343880

Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343880

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343880

Opiate antagonist treatment of ovarian failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343880

Increased circulating levels of immunoreactive beta-endorphin in polycystic ovary syndrome is not caused by increased pituitary secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343880

Prolonged opioid blockade with naltrexone and luteinizing hormone modifications in women with polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343880

The effects of insulin and insulin-like growth factors-I and -II on estradiol production by granulosa cells of polycystic ovaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03343880

Successful induction of ovulation in normogonadotrophic clomiphene resistant anovulatory women by combined naltrexone and clomiphene citrate treatment

21 January 2018

1 reference

12 December 2020

A Normal Cumulative Conception Rate after Human Pituitary Gonadotropin

1 reference

12 December 2020

Detection and characterization of peaks and estimation of instantaneous secretory rate for episodic pulsatile hormone secretion

1 reference

12 December 2020

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

1 reference

12 December 2020

Pulsatile luteinizing hormone secretion in hypothalamic amenorrhea, anorexia nervosa, and polycystic ovarian disease during naltrexone treatment

1 reference

12 December 2020

The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome

1 reference

12 December 2020

Polycystic ovary syndrome. Insulin resistance and ovulatory responses to clomiphene citrate.

1 reference

12 December 2020

Mechanism and management of ovulatory failure in women with polycystic ovary syndrome

1 reference

12 December 2020

Treatment with naltrexone in hypothalamic ovarian failure: induction of ovulation and pregnancy

1 reference

12 December 2020

Ovarian hyperstimulation syndrome: an update review.

1 reference

12 December 2020

Evidence of a distinct derangement of opioid tone in hyperinsulinemic patients with polycystic ovarian syndrome: relationship with insulin and luteinizing hormone secretion

1 reference

12 December 2020

Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles

1 reference

12 December 2020

Increased insulin secretion in patients with multifollicular and polycystic ovaries and its impact on ovulation induction

1 reference

12 December 2020

Long-term naltrexone treatment normalizes the pituitary response to gonadotropin-releasing hormone in polycystic ovarian syndrome

1 reference

12 December 2020

Circulating luteinizing hormone pulse frequency in women with polycystic ovary syndrome

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03343880

1 reference

Dimensions Publication ID

1 November 2017

1016975891

0 references

1 reference